Since 1999, Genoptix has provided the vital insights Cancer Care Teams need to achieve the best possible outcome for each and every patient. Our testing services combine data from pathology expertise and next-generation testing into one tailored report for optimizing precision medicine. With over 1.7 million patients served, Genoptix sets a higher standard of quality, from science to service.